Religare IPO to open on Oct 29
Religare Enterprises, a financial services provider promoted by Ranbaxy Laboratories, is entering the capital market with its initial public offer of 75.76 lakh shares.
The price band has been fixed at Rs 160 to Rs 185. Religare Enterprises is a holding company of 11 subsidiaries, which are engaged in offering financial services targeted at retail, high networth individuals besides corporate and institutional clients.
The company recently sold 5% stake to Indopark Holdings, a subsidiary of Merrill Lynch, for Rs 60.6 crore.
Download ET Markets APP